Long-Term Maintenance of Normal Human Skin on Congenitally Athymic (Nude) Mice

1973 ◽  
Vol 143 (2) ◽  
pp. 350-353 ◽  
Author(s):  
N. D. Reed ◽  
D. D. Manning
1975 ◽  
Vol 64 (5) ◽  
pp. 307-312 ◽  
Author(s):  
G.G. Krueger ◽  
Dean D. Manning ◽  
James Malouf ◽  
Bruce Ogden

2004 ◽  
Vol 150 (4) ◽  
pp. 658-667 ◽  
Author(s):  
S. Del Bino ◽  
C. Vioux ◽  
P. Rossio-Pasquier ◽  
A. Jomard ◽  
M. Demarchez ◽  
...  

1990 ◽  
Vol 416 (6) ◽  
pp. 505-511 ◽  
Author(s):  
Jean Kanitakis ◽  
Ana Ramirez-Bosca ◽  
Marek Haftek ◽  
Jean Thivolet

1998 ◽  
Vol 110 (6) ◽  
pp. 978-981 ◽  
Author(s):  
Sergio Di Nuzzo ◽  
Regien M.R. Sylva-Steenland ◽  
Menno A. de Rie ◽  
Pranab K. Das ◽  
Jan D. Bos ◽  
...  

1984 ◽  
Vol 12 (2) ◽  
pp. 89-97
Author(s):  
Graham R. Elliott ◽  
H.E. Amos ◽  
James W. Bridges

The rate of growth of normal human skin fibroblasts was inhibited in a dose related, reversible, fashion by practolol (N-4-(2-hydroxy)-3 (1-methyl)-aminopropoxyphenylacetamine) (ID50 1.35 ± 0.14 x 10-3M), propranolol (1-(isopropylamino)-3(1-naphthyl-oxy)-2-propranolol) (ID50 0.145 ± 0.02 x 10-3M) and paracetamol (N-(4-hydroxyphenyl) acetamide) (ID50 0.85 ± 0.2 x 10-3M). Skin fibroblasts isolated from a psoriasis patient were more sensitive towards practolol (ID50 0.48 ± 0.14 x 10-3M) and propranolol (ID50 0.032 ± 0.002 x 10-3M), but less sensitive towards paracetamol (ID50 1.3 ± 0.07 x 10-3M). In vitro generated metabolites of practolol, using normal or Arochlor 1254-pretreated hamster liver preparations, and structural analogues of practolol had no effect upon the growth of either cell type.


Sign in / Sign up

Export Citation Format

Share Document